Literature DB >> 636408

Meningococcal disease in California. Epidemiology and management.

C Juels, F R Morrison, G D Overturf, R R Roberto, J C Chin.   

Abstract

Between 1969 and 1975 in California, 1,953 cases of meningococcal disease were reported. For cases reported in 1973, 1974 and 1975, detailed information about chemoprophylaxis of cases and contacts was obtained in addition to demographic and laboratory data. A review of data for the seven years showed a reduction in the case rate from 2.6 to 0.6 per 100,000 population, but this drop was due primarily to a very substantial decline in the military rate from 35.7 to 1.8 per 100,000 population. No reduction was apparent in the case fatality rate. Five groups of associated meningococcal disease cases were identified for a total of nine secondary or coprimary cases among 862 household contacts. Associated cases occurred in 10.4 per 1,000 household contacts-a rate several hundred times greater than that for the general population. THE STUDY FINDINGS INDICATE THAT MANY PHYSICIANS ARE UNAWARE OF THE FOLLOWING: (1) nonhousehold contacts are at little or no risk of contracting meningococcal disease; (2) prophylaxis should be offered only to household or intimate contacts immediately upon identification of an index case without waiting for test results for meningococcal carriage; (3) valid medical and epidemiologic indications exist for administering prophylaxis to household contacts who are culture negative as well as those who are culture positive; (4) the current drug of choice for prophylaxis is rifampin, but since no drug is completely effective, close medical observation remains the most important factor in the management of household or intimate contacts to meningococcal disease.

Entities:  

Mesh:

Year:  1978        PMID: 636408      PMCID: PMC1238050     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  10 in total

1.  Vestibular reactions associated with minocycline.

Authors:  J A Jacobson; B Daniel
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

2.  IN VIVO AND IN VITRO RESISTANCE TO SULFADIAZINE IN STRAINS OF NEISSERIA MENINGITIDIS.

Authors:  J W MILLAR; E E SIESS; H A FELDMAN; C SILVERMAN; P FRANK
Journal:  JAMA       Date:  1963-10-12       Impact factor: 56.272

3.  The reporting of communicable diseases.

Authors:  R Marier
Journal:  Am J Epidemiol       Date:  1977-06       Impact factor: 4.897

4.  Attempted prophylaxis against meningococcal infection using intramuscular penicillin.

Authors:  M S Artenstein; T H Lamson; J R Evans
Journal:  Mil Med       Date:  1967-12       Impact factor: 1.437

5.  Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci.

Authors:  J M Dowd; D Blink; C H Miller; P F Frank; W E Pierce
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

6.  Trends in meningococcal disease, 1974.

Authors:  J A Jacobson; R E Weaver; C Thornsberry
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

7.  Meningococcal meningitis following rifampin prophylaxis.

Authors:  N Khuri-Bulos
Journal:  Am J Dis Child       Date:  1973-11

8.  Epidemic disease due to serogroup C Neisseria meningitidis in Saõ Paulo, Brazil.

Authors:  J Souza de Morais; R S Munford; J B Risi; E Antezana; R A Feldman
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

9.  Minocycline for prophylaxis of infection with Neisseria meningitidis: high rate of side effects in recipients.

Authors:  T M Drew; R Altman; K Black; M Goldfield
Journal:  J Infect Dis       Date:  1976-02       Impact factor: 5.226

10.  Penicillins in the treatment of bacterial meningitis.

Authors:  A W Mathies
Journal:  J R Coll Physicians Lond       Date:  1972-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.